Comparative analysis of the transcriptome and methylome in distinct trophoblast populations at the time of embryo implantation in mares.

This study compared gene activity and DNA methylation in two horse trophoblast types—the invasive chorionic girdle and the non-invasive allantochorion—around implantation (days 33–42). It links specific expression and epigenetic patterns to adhesion, immune modulation, and MHC I control, indicating coordinated transcriptional–epigenetic regulation of invasion and maternal tolerance.

What the researchers set out to discover

• Whether invasive (chorionic girdle, CG) and non-invasive (allantochorion) trophoblasts use distinct gene programs and DNA methylation states to drive implantation, tissue attachment, and maternal immune tolerance.
• How these programs change across the immediate peri-implantation window in mares (gestational days 33 to 42).
• Which pathways (for example, TGFβ signaling, cell adhesion, immune regulation) are convergently regulated at both the transcriptome and methylome levels.

Study design and approach

• Populations profiled:
  • Invasive chorionic girdle trophoblast (CG), sampled at day 33 (CG33).
  • Non-invasive allantochorion trophoblast (ALC), sampled at day 33 (ALC33) and assessed across the window to day 42.
• Omics layers:
  • Transcriptome profiling to measure gene expression differences between lineages and over time.
  • Methylome profiling to identify differentially methylated regions/genes that could regulate those expression differences.
• Sample sizes indicated in the abstract:
  • Allantochorion n = 4 (irrespective of day); CG33 n = 4; ALC33 n = 4.
• Analyses:
  • Differential expression (between CG vs allantochorion; and day 33 vs day 42 where applicable).
  • Differential methylation aligned to genes to find expression–methylation concordance.
  • Gene Ontology and pathway enrichment to contextualize functional themes.

Key molecular findings by trophoblast lineage and time

• Allantochorion (non-invasive) signature:
  • Consistent enrichment of TGFβ ligand (TGFB) and receptors (TGFBR1, TGFBR2) regardless of gestational day, highlighting a stable TGFβ-axis tone in this tissue.
  • Across days 33 → 42, increased expression of markers associated with regulatory/polarized macrophages and immune modulation:
    • IL33 (alarmin cytokine that can condition tissue-resident and infiltrating immune cells).
    • PLG-RKT (plasminogen receptor; can link to extracellular matrix remodeling and immune cell dynamics).
    • CD163 (canonical marker of regulatory/M2-like macrophages).
  • Upregulation of TFEB (master regulator of lysosomal biogenesis and cellular metabolism) and SERPINB9 (granzyme B inhibitor that can protect target cells from cytotoxic T cell/NK cell attack).
  • Temporal decline of NLRC5 in allantochorion from day 33 to 42, suggesting a reduction in the transcriptional drive for classical MHC I expression as implantation proceeds.
  • Hypermethylation of B2M (β2-microglobulin, the MHC I light chain), consistent with epigenetic down-tuning of MHC I surface expression.
• Chorionic girdle (invasive) signature at day 33:
  • Higher expression of NLRC5 relative to ALC33, indicating a lineage-specific propensity to support MHC I transcription at the invasive stage.
  • Genes showing joint differential expression and methylation (for example, CAVIN1, LHB, INSR) demarcate membrane organization/metabolism and endocrine signaling differences that may underlie invasive capacity and trophoblast specialization.
• Across the implantation window (temporal regulation):
  • Genes such as IFNGR1 and CD177 displayed time-dependent changes, pointing to shifts in interferon responsiveness and neutrophil-related biology during progression to stable attachment.

Integrated epigenetic–transcriptional regulation

• Epigenetic control of antigen presentation:
  • B2M hypermethylation in allantochorion is consistent with reduced MHC I complex formation and surface presentation.
  • Concomitant differences in NLRC5 (a transactivator of MHC I pathway genes) between lineages and over time suggest coordinated epigenetic and transcriptional governance of MHC I levels.
• Concordant differential expression and methylation:
  • CAVIN1 (caveolae biogenesis), LHB (hormone subunit), and INSR (insulin receptor) were both differentially expressed and methylated between trophoblast types, implying methylation-linked tuning of endocrine, metabolic, and membrane architecture programs relevant to implantation dynamics.
• Differentially regulated over time:
  • IFNGR1 and CD177 varied across days 33–42, aligning with evolving immune–inflammatory landscapes as attachment consolidates.

Pathways and processes enriched

• Cell migration and adhesion: core to trophoblast attachment and controlled invasion.
• TGFβ signaling: central immunoregulatory and pro-tolerance pathway, also influencing extracellular matrix (ECM) remodeling.
• Fibrosis and wound healing: reflect the endometrium’s remodeling response to implantation, balancing repair with integration.
• Leukocyte extravasation: regulation of immune cell trafficking into the maternal–fetal interface.

Biological interpretation and proposed roles

• Allantochorion as an immune-modulatory, non-invasive interface:
  • IL33 and CD163 upregulation suggests recruitment/polarization of macrophages toward a regulatory phenotype that supports tolerance and tissue remodeling.
  • Persistent TGFβ signaling (ligand and receptors) likely reinforces anti-inflammatory signaling and ECM organization, maintaining non-invasive, adhesive interactions.
  • SERPINB9 may protect trophoblast cells from cytotoxic granzyme-mediated killing, contributing to immune evasion compatible with tolerance.
  • TFEB upregulation may support metabolic reprogramming and functional maturation, potentially intersecting with cholesterol/sterol handling needed for endocrine functions.
  • Reduced NLRC5 and hypermethylated B2M converge on dampened classical MHC I expression, lowering immune visibility as implantation stabilizes.
• Chorionic girdle as an invasive, signaling-distinct trophoblast:
  • Higher NLRC5 at day 33 indicates a different MHC I regulatory setpoint during the invasive phase, which may influence interactions with maternal immune cells during endometrial breaching and early cup formation.
  • Jointly regulated genes (e.g., CAVIN1, LHB, INSR) point to differences in membrane dynamics, endocrine identity, and nutrient/hormone sensitivity that may facilitate invasion and subsequent lineage-specific functions.

Why this matters

• Defines lineage- and time-specific immune and adhesion programs at the equine maternal–fetal interface, a unique implantation model among domestic mammals.
• Highlights epigenetic mechanisms as key levers for tuning antigen presentation and invasion, informing comparative placentation and potential causes of implantation failure.
• Identifies candidate biomarkers and pathways (TGFβ axis, IL33–CD163 macrophage circuit, MHC I regulators) that may be leveraged for diagnostic monitoring or therapeutic modulation in equine reproduction.

Strengths and limitations

• Strengths:
  • Integrated analysis of transcriptome and methylome provides mechanistic depth beyond expression alone.
  • Direct comparison of spatially distinct trophoblast lineages with temporal resolution across the implantation window.
  • Pathway-level synthesis links gene-level changes to implantation-relevant biology.
• Limitations (inferred from the abstract):
  • Sample sizes are modest (n = 4 per group), which may limit power for subtle effects.
  • Observational omics without functional perturbation; causality remains to be tested.
  • Details of methylation context (promoter vs gene body vs enhancer) and cell heterogeneity are not specified, which can affect interpretation.
  • Temporal sampling of CG appears centered on day 33; later invasive states may not be fully captured.

Conceptual model of implantation in mares emerging from the data

• Day ~33:
  • CG exhibits higher NLRC5, supporting MHC I transcription during initial invasion readiness.
  • Allantochorion displays active TGFβ signaling with relatively higher immune visibility than later stages.
• Progressing to day ~42:
  • Allantochorion amplifies immunoregulatory cues (IL33, CD163), recruits/polarizes regulatory macrophages, and increases SERPINB9 and TFEB for protection and maturation.
  • Allantochorion reduces MHC I pathway activity (lower NLRC5; B2M hypermethylation), decreasing antigen presentation as attachment consolidates.
  • Pathways in adhesion, ECM remodeling, wound-healing-like processes, and leukocyte trafficking orchestrate stable placental integration.

Next steps and open questions

• Validate protein-level changes and cell-surface expression (e.g., MHC I, CD163) in situ across days 33–42.
• Functionally test roles of IL33–CD163 signaling, TGFβ axis, SERPINB9, and TFEB in trophoblast–immune cell crosstalk and adhesion using ex vivo or organoid models.
• Map methylation changes to specific regulatory elements (promoters/enhancers) and assess chromatin accessibility to refine causal links to expression.
• Resolve cell-type composition and heterogeneity with single-cell or spatial omics to distinguish trophoblast-intrinsic changes from infiltrating immune cells.
• Examine whether similar MHC I regulatory strategies occur in other species with distinct implantation strategies to delineate conserved vs species-specific mechanisms.

Key terms and gene roles (brief)

• NLRC5: transactivator of MHC I pathway genes; modulates antigen presentation.
• B2M: light chain of MHC I; necessary for stable MHC I surface expression; hypermethylation typically represses expression.
• IL33: alarmin cytokine influencing type 2/regulatory immune responses and tissue repair.
• CD163: scavenger receptor marking regulatory/M2-like macrophages associated with tolerance and remodeling.
• TGFβ/TGFBR1/2: canonical immunoregulatory and ECM-remodeling pathway.
• SERPINB9: endogenous inhibitor of granzyme B, protecting cells from cytotoxic lymphocyte-mediated apoptosis.
• TFEB: transcription factor controlling lysosome and autophagy genes; supports cellular metabolism and maturation.
• CAVIN1: caveolae structural component; affects membrane mechanics and signaling.
• LHB: luteinizing hormone beta subunit; denotes endocrine features relevant to equine pregnancy.
• INSR: insulin receptor; links metabolic signaling to growth and differentiation.
• IFNGR1 and CD177: interferon receptor and neutrophil-associated marker, respectively; indicate evolving inflammatory/immune milieu.